<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Haas Temple | Activity</title>
	<link>http://toxicdolls.com/members/jeansweed9/activity/</link>
	<atom:link href="http://toxicdolls.com/members/jeansweed9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Haas Temple.</description>
	<lastBuildDate>Mon, 09 Nov 2026 22:28:27 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">32cebf3df83de43175abbb6bb2446ef4</guid>
				<title>Haas Temple posted an update: In questi recenti anni, l&#039;ambito farmaceutico ha [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/61561/</link>
				<pubDate>Sat, 19 Jul 2025 11:35:59 +0000</pubDate>

									<content:encoded><![CDATA[<p>In questi recenti anni, l&#8217;ambito farmaceutico ha sperimentato una evoluzione radicale, condotta da innovazioni scientifico e tecnologiche che hanno fatto molto efficaci e accessibili i rimedi per una grande varietà di malattie. I composti farmaceutici, che costituiscono la fondamento di trattamenti contemporanee, hanno subito un progresso&hellip;<span class="activity-read-more" id="activity-read-more-61561"><a href="http://toxicdolls.com/activity-2/p/61561/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9dfb5f934440c5970aae8d7eda504026</guid>
				<title>Haas Temple became a registered member</title>
				<link>http://toxicdolls.com/activity-2/p/60232/</link>
				<pubDate>Fri, 18 Jul 2025 10:46:03 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>